Elanco Animal Health Incorporated Financial Ratios — ELAN

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	-1.36	-4.2	1.33	1.27	-8.19	-6.04	-1.05	-18.22	5.49	-3.67
Return on Assets (%)	- -	-1.18	-3.65	0.97	0.76	-4.3	-2.83	-0.49	-8.25	2.51	-1.79
Return on Capital (%)	- -	- -	- -	1.41	1.76	- -	- -	- -	- -	4.47	- -
Return on Invested Capital (%)	- -	- -	- -	3.08	4.16	- -	- -	- -	- -	1.55	- -
Gross Margin (%)	47.28	51.64	48.29	48.68	52.13	49.04	55.25	56.63	56.28	54.88	54.99
EBITDA Margin (%)	8.33	18.45	15.95	19.88	22.31	13.3	21.41	24.17	23.09	20.57	19.77
Operating Margin (%)	0.19	9.72	4.93	10.23	12.08	-2.51	6.38	8.71	7.38	5.65	5.34
Incremental Operating Margin (%)	- -	6,313.64	574.69	96.4	1,361.9	- -	25.85	-22.66	-966.67	-340.91	0.36
Pretax Margin (%)	-8.92	-0.77	-8.05	3.72	2.54	-20.7	-11.99	-1.63	-27.05	10.99	-4.75
Profit Margin (%)	-7.25	-1.64	-10.75	2.82	2.21	-17.55	-10.14	-1.77	-27.87	7.61	-4.92
Net Income to Common Margin (%)	-7.25	-1.64	-10.75	2.82	2.21	-17.55	-10.14	-1.77	-27.87	7.61	-4.92
Effective Tax Rate (%)	- -	- -	- -	24.19	12.82	- -	- -	- -	- -	30.74	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-1.36	-4.2	1.33	1.27	-8.19	-6.04	-1.05	-18.22	5.49	-3.67

Credit (USD)

Credit Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	2,472	2,355	6,127	6,319	5,836	5,774	4,321	4,017
ST Debt	- -	- -	- -	29	24	555	294	388	38	44	74
LT Debt	- -	- -	- -	2,443	2,330	5,572	6,025	5,448	5,736	4,277	3,943
Total Debt/EBITDA	- -	- -	- -	4.05	3.44	14.09	6.2	5.47	5.66	4.73	4.31
Net Debt/EBITDA	- -	-0.48	-0.7	3.28	2.95	12.95	5.57	5.15	5.32	4.22	3.73
Total Debt/EBIT	- -	- -	- -	7.88	6.35	-74.72	20.79	15.2	17.71	17.22	15.94
Net Debt/EBIT	- -	-0.91	-2.27	6.37	5.45	-68.68	18.69	14.3	16.63	15.35	13.78
EBITDA to Interest Expense	- -	- -	- -	20.6	8.67	2.9	4.32	4.42	3.68	3.89	4.24
EBITDA-CapEx/Interest Expense	- -	- -	- -	15.99	6.18	0.83	3.49	3.66	3.13	3.2	2.98
EBIT to Interest Expense	- -	- -	- -	10.6	4.7	-0.55	1.29	1.59	1.18	1.07	1.15
Interest Expense	- -	- -	- -	30	79	150	236	241	277	235	220
Common Equity/Total Assets	- -	86.77	87.03	58.03	61.73	47.91	45.56	47.05	43.33	48.33	49.01
Long-Term Debt/Equity (%)	- -	- -	- -	47.01	42.01	65.74	80.25	74.74	92.17	70.16	60.23
Long-Term Debt/Capital (%)	- -	- -	- -	31.86	29.49	38.16	43.57	41.51	47.81	41.06	37.32
Long-Term Debt/Total Assets (%)	- -	- -	- -	27.28	25.94	31.49	36.56	35.17	39.94	33.91	29.52
Total Debt/Equity (%)	- -	- -	- -	47.57	42.46	72.29	84.16	80.07	92.78	70.88	61.36
Total Debt/Capital (%)	- -	- -	- -	32.23	29.8	41.96	45.7	44.46	48.13	41.48	38.03
Total Debt/Total Assets (%)	- -	- -	- -	27.6	26.21	34.63	38.35	37.67	40.2	34.26	30.07
Net Debt to Equity	- -	-3.68	-4.16	38.43	36.43	66.45	75.67	75.33	87.13	63.21	53.03
Net Debt/Capital (%)	- -	-3.82	-4.34	27.76	26.7	39.92	43.07	42.97	46.56	38.73	34.65
EBITDA	242	538	461	610	685	435	1,020	1,066	1,020	913	932
EBITDA-CapEx	142	427	344	473	488	124	823	882	866	752	656
Operating Income (Loss)	5	283	142	314	371	-82	304	384	326	251	252

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.42	0.5	0.49	0.41	0.24	0.39	0.2	0.28	0.36	0.34
Current Ratio	- -	3.15	3.3	2.58	2.9	1.65	1.99	1.93	2.75	2.44	2.17
Quick Ratio	- -	1.44	1.44	1.22	1.5	0.76	1.01	0.79	1.1	1.03	0.93
CFO/Avg Current Liab	- -	0.5	0.28	0.6	0.25	-0.03	0.26	0.27	0.18	0.42	0.38
Common Equity/Total Assets	- -	86.77	87.03	58.03	61.73	47.91	45.56	47.05	43.33	48.33	49.01
Long-Term Debt/Equity (%)	- -	- -	- -	47.01	42.01	65.74	80.25	74.74	92.17	70.16	60.23
Long-Term Debt/Capital (%)	- -	- -	- -	31.86	29.49	38.16	43.57	41.51	47.81	41.06	37.32
Long-Term Debt/Total Assets (%)	- -	- -	- -	27.28	25.94	31.49	36.56	35.17	39.94	33.91	29.52
Total Debt/Equity (%)	- -	- -	- -	47.57	42.46	72.29	84.16	80.07	92.78	70.88	61.36
Total Debt/Capital (%)	- -	- -	- -	32.23	29.8	41.96	45.7	44.46	48.13	41.48	38.03
Total Debt/Total Assets (%)	- -	- -	- -	27.6	26.21	34.63	38.35	37.67	40.2	34.26	30.07
CFO/Total Liabilities	- -	14.55	14.98	12.96	6.51	-0.44	5.38	5.51	3.33	8.3	8.22
CFO/CapEx	0.07	1.41	1.48	3.57	1.14	-0.13	2.45	2.46	1.76	3.36	2.03
Altman's Z-Score	- -	1.88	1.56	3.55	3.7	1.72	2.24	1.73	1.57	1.62	1.9

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	9.96	5.01	5.03	4.18	3.87	5.59	5.41	5.39	5.39	5.62
Days Sales Outstanding	- -	36.64	72.8	72.55	87.28	94.23	65.32	67.44	67.72	67.71	64.95
Inventory Turnover	- -	3.22	1.54	1.52	1.43	1.27	1.45	1.32	1.18	1.21	1.28
Days Inventory Outstanding	- -	113.41	236.74	239.62	255.1	287.79	252.44	277.52	309.33	301.49	284.76
Accounts Payable Turnover	- -	20.02	7.78	7.41	7.09	6.06	4.2	5.16	6.45	6.51	6.88
Accounts Payable Turnover Days	- -	18.23	46.91	49.25	51.48	60.18	86.94	70.72	56.6	56.08	53.03
Cash Conversion Cycle	- -	131.83	262.63	262.93	290.9	321.83	230.81	274.24	320.45	313.13	296.67
Inventory to Cash Days	- -	-76.77	-163.94	-167.07	-167.82	-193.56	-187.12	-210.08	-241.61	-233.78	-219.81
Inventories	- -	876	1,062	1,004	1,051	1,578	1,371	1,538	1,735	1,574	1,737
Raw Materials	- -	60	70	80	84	210	254	130	128	98	104
Work In Process	- -	453	580	570	603	625	565	683	814	783	837
Finished Goods	- -	410	452	401	403	772	598	783	857	754	871
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	11,529	10,985	14,474	13,427	5,795	7,343	5,988	11,247
- Cash & Cash Equivalents	- -	259	323	475	334	495	638	345	352	468	545
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	2,472	2,355	6,127	6,319	5,836	5,774	4,321	4,017
Enterprise Value	- -	-259	-323	13,526	13,006	20,106	19,108	11,286	12,765	9,841	14,719
Total Capital	- -	7,028	7,780	7,670	7,902	14,603	13,827	13,125	11,997	10,417	10,564
Total Debt/Capital (%)	- -	- -	- -	32.23	29.8	41.96	45.7	44.46	48.13	41.48	38.03
Total Debt / EV	- -	- -	- -	0.18	0.18	0.3	0.33	0.52	0.45	0.44	0.27
EV/Sales	- -	- -	- -	4.41	4.24	6.15	4.01	2.56	2.89	2.22	3.12
EV/EBITDA	- -	- -	- -	22.18	18.99	46.22	18.73	10.59	12.52	10.78	15.79
EV/EBIT	- -	- -	- -	43.1	35.06	- -	62.86	29.39	39.16	39.21	58.41
EV/Cash Flow to Firm	- -	- -	- -	26.54	44.41	233.3	27.99	15.83	22.95	13.98	18.68
EV/Free Cash Flow to Firm	- -	- -	- -	20.93	26.55	50.62	21.72	12.58	17.97	11.38	13.84
Diluted Market Cap	- -	- -	- -	9,891	10,905	13,538	13,827	5,967	7,335	6,022	11,234
Diluted Enterprise Value	- -	-259	-323	11,888	12,926	19,170	19,508	11,458	12,757	9,875	14,706
EV per Share	- -	- -	- -	36.99	34.87	42.6	40.39	23.8	25.9	19.9	29.62
TTM Sales	2,909	2,914	2,889	3,067	3,071	3,271	4,764	4,411	4,417	4,439	4,715
TTM EBITDA	242	538	461	610	685	435	1,020	1,066	1,020	913	932
TTM Operating Income	5	283	142	314	371	-82	304	384	326	251	252
TTM Cash Flow to Firm	7	156	174	510	293	86	683	713	556	704	788
TTM Free Cash Flow to Firm	107	266	291	646	490	397	880	897	710	865	1,064

Multiples (USD)

Valuation Multiples API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	15.86	25.9	50.14	20.33	9.38	17.26	8.58	13.44
EV/EBIT	- -	- -	- -	43.1	35.06	- -	62.86	29.39	39.16	39.21	58.41
Enterprise Value	- -	-259	-323	13,526	13,006	20,106	19,108	11,286	12,765	9,841	14,719
Low Price	- -	- -	- -	28.85	25.25	15.17	27.16	11.18	7.88	11.4	8.02
EV/Sales	- -	- -	- -	4.41	4.24	6.15	4.01	2.56	2.89	2.22	3.12
EV/EBITDA	- -	- -	- -	22.18	18.99	46.22	18.73	10.59	12.52	10.78	15.79
Price/Earnings	- -	- -	- -	114.35	159.81	- -	- -	- -	- -	17.7	- -
Price/Earnings Average	- -	- -	- -	119.61	163.26	-20.26	-32.39	-125.27	-4.4	21.4	-33.11
Price/Earnings High	- -	- -	- -	136.4	192.42	-26.21	-37.82	-185.68	-6.04	27.48	-50.71
Price/Earnings Low	- -	- -	- -	104.63	137.02	-11.67	-27.4	-69.99	-3.15	16.66	-17.16
Price/Book Value	- -	- -	- -	2.22	1.98	1.71	1.79	0.8	1.18	0.98	1.72
Price/Book Value Average	- -	- -	- -	2.32	2.02	1.47	2.02	1.3	0.87	1.19	1.17
Price/Book Value High	- -	- -	- -	2.65	2.38	1.9	2.36	1.93	1.2	1.52	1.8
Price/Book Value Low	- -	- -	- -	2.03	1.7	0.84	1.71	0.73	0.62	0.92	0.61
Price/Tangible Book Value	- -	- -	- -	-43.46	147.45	-3.5	-3.16	-1.63	-2.18	-3	-6.86
Price/Tangible Book Value Average	- -	- -	- -	-45.46	150.63	-3.01	-3.57	-2.68	-1.61	-3.62	-4.69
Price/Tangible Book Value High	- -	- -	- -	-51.84	177.54	-3.89	-4.17	-3.97	-2.21	-4.65	-7.18
Price/Tangible Book Value Low	- -	- -	- -	-39.76	126.42	-1.73	-3.02	-1.5	-1.15	-2.82	-2.43
Price/Sales	- -	- -	- -	3.23	3.54	4.14	2.9	1.35	1.66	1.35	2.38
Price/Sales Average	- -	- -	- -	3.37	3.61	3.55	3.28	2.22	1.23	1.63	1.63
Price/Sales High	- -	- -	- -	3.85	4.26	4.6	3.83	3.28	1.68	2.09	2.5
Price/Sales Low	- -	- -	- -	2.95	3.03	2.05	2.78	1.24	0.88	1.27	0.84
Price/Cash Flow	- -	- -	- -	20.3	48.51	-330.19	28.63	13.2	27.07	11.06	20.06
Price/Cash Flow Average	- -	- -	- -	21.23	49.56	-283.59	32.39	21.62	20	13.37	13.72
Price/Cash Flow High	- -	- -	- -	24.21	58.41	-367.01	37.82	32.04	27.43	17.17	21.01
Price/Cash Flow Low	- -	- -	- -	18.57	41.59	-163.32	27.4	12.08	14.31	10.41	7.11
Price/Free Cash Flow Average	- -	- -	- -	16.59	26.46	43.06	23.01	15.36	12.75	10.37	9.19
Price/Free Cash Flow High	- -	- -	- -	18.91	31.19	55.73	26.86	22.77	17.49	13.32	14.07
Price/Free Cash Flow Low	- -	- -	- -	14.51	22.21	24.8	19.46	8.58	9.13	8.08	4.76
EV/Sales Average	- -	- -	- -	4.58	4.31	5.52	4.38	3.4	2.46	2.5	2.37
EV/Sales High	- -	- -	- -	5.14	4.97	6.64	4.92	4.43	2.91	2.96	3.23
EV/Sales Low	- -	- -	- -	4.09	3.73	3.91	3.89	2.45	2.11	2.14	1.58
EV/EBITDA Average	- -	-0.48	-0.7	23.05	19.33	41.52	20.46	14.05	10.63	12.15	11.98
EV/EBITDA High	- -	-0.48	-0.7	25.83	22.26	49.93	22.96	18.35	12.61	14.4	16.36
EV/EBITDA Low	- -	-0.48	-0.7	20.57	16.7	29.4	18.17	10.12	9.12	10.39	8
EV/EBIT Average	- -	-0.91	-2.27	44.8	35.7	-220.28	68.66	39.01	33.27	44.19	44.29
EV/EBIT High	- -	-0.91	-2.27	50.19	41.1	-264.88	77.03	50.93	39.46	52.38	60.52
EV/EBIT Low	- -	-0.91	-2.27	39.98	30.83	-155.99	60.96	28.11	28.54	37.81	29.59
Last Price	- -	- -	- -	31.53	29.45	30.67	28.38	12.22	14.9	12.11	22.63
High Price	- -	- -	- -	37.61	35.46	34.09	37.49	29.66	15.1	18.8	23.7
Enterprise Value Average	- -	-259	-323	14,057	13,243	18,063	20,873	14,981	10,847	11,092	11,162
Enterprise Value High	- -	-259	-323	15,749	15,248	21,720	23,418	19,557	12,864	13,149	15,250
Enterprise Value Low	- -	-259	-323	12,546	11,440	12,791	18,531	10,793	9,306	9,490	7,458

Shares Outstanding	- -	356	366	366	373	472	473	474	493	494	497
Diluted Weighted Avg Shares	356	356	356	314	370	441	487	488	492	497	496
Basic Weighted Avg Shares	356	356	356	314	369	441	487	488	492	494	496
Revenue per Share	8.17	8.18	8.11	9.78	8.32	7.41	9.78	9.03	8.97	8.99	9.5
EBITDA per Share	0.68	1.51	1.29	1.94	1.86	0.99	2.09	2.18	2.07	1.85	1.88
Operating Income per Share	0.02	0.8	0.4	1	1.01	-0.19	0.62	0.79	0.66	0.51	0.51
Basic EPS, GAAP	-0.59	-0.13	-0.87	0.28	0.18	-1.3	-0.99	-0.16	-2.5	0.68	-0.47
Basic EPS from Cont Ops	-0.59	-0.13	-0.87	0.28	0.18	-1.3	-0.99	-0.16	-2.5	0.68	-0.47
Diluted EPS, GAAP	-0.59	-0.13	-0.87	0.28	0.18	-1.3	-0.99	-0.16	-2.5	0.68	-0.47
Diluted EPS from Cont Ops	-0.59	-0.13	-0.87	0.28	0.18	-1.3	-0.99	-0.16	-2.5	0.68	-0.47
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.02	0.44	0.49	1.55	0.61	-0.09	0.99	0.93	0.55	1.1	1.13
Free Cash Flow per Basic Share	-0.26	0.13	0.16	1.12	0.07	-0.8	0.59	0.55	0.24	0.77	0.57
Cash & Equivalents per Share	- -	0.73	0.88	1.3	0.9	1.05	1.35	0.73	0.71	0.95	1.1
Book Value per Share	- -	19.73	21.28	14.21	14.87	17.96	15.87	15.37	12.63	12.33	13.17
Tangible Book Value per Share	- -	5.14	5.85	-0.73	0.2	-8.76	-8.99	-7.48	-6.83	-4.04	-3.3

Elanco Animal Health Incorporated

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)